申请人:ZENECA LIMITED
公开号:EP0897913A1
公开(公告)日:1999-02-24
The present invention concerns novel carboxamide derivatives of formula I, set out hereinbelow which antagonize the pharmacological actions of one of the endogenous neuropeptide tachykinins at the neurokinin 2 (NK2) receptor, making them useful whenever such antagonism is desired, such as in the treatment of asthma and related conditions. The invention also provides pharmaceutical compositions containing the novel carboxamide derivatives for use in such treatment, methods for their use, and processes and intermediates for the manufacture of the novel carboxamide derivatives.
本发明涉及式 I 的新型羧酰胺衍生物,如下所述,其可拮抗内源性神经肽之一速激肽在神经激肽 2 (NK2) 受体上的药理作用,使其在任何需要这种拮抗作用的情况下都有用,例如在治疗哮喘和相关疾病中。本发明还提供了含有用于此类治疗的新型羧酰胺衍生物的药物组合物、其使用方法以及用于制造新型羧酰胺衍生物的工艺和中间体。